PR97443

TIANJIN, China, Aug. 17, 2022 /PRNewswire=KYODO JBN/ --

- JOYSBIO, one of the world's leading manufacturers of rapid test kits, has

developed two new Monkeypox tests that deliver results in 15 minutes

JOYSBIO, one of the world's leading manufacturers of lateral flow rapid test

kits, is proud to announce the development of two Monkeypox tests, both of

which deliver results in 15 minutes or less. JOYSBIO recently launched a

Monkeypox Antigen Rapid test and a Monkeypox IgM/IgG Antibody Rapid test, both

are CE-IVD marked. The antigen test tests specimens from human serum, plasma,

whole blood, throat swab, saliva, or lesion exudate to determine if there are

monkeypox virus antigens. The IgM/IgG Antibody test uses a few drops of blood

to find the antibodies that a person's body created after the monkeypox

infection. Both tests are currently in clinical evaluation in Europe and showed

reliable results with infected patients.  More information is available at

https://en.joysbio.com/monkeypox-rapid-test-kit/

(https://en.joysbio.com/monkeypox-rapid-test-kit/).

"On the heels of COVID-19, another global health concern, monkeypox," said Rick

Zhang, Business Development Director for JOYSBIO. "Fortunately, we have

treatments for monkeypox that can reduce the painful lesions and likelihood of

death. We also have a vaccine for this disease since it's been around for a

very long time. Still, before patients can be treated, they need to be properly

diagnosed. Monkeypox looks like many other pox diseases. Our tests will be a

great tool for healthcare professionals, especially when having limited access

to PCR tests."

Monkeypox has had a historical fatality rate of 0.1% to 11% in the general

population, but it is much more of a concern among children where the fatality

rate can skyrocket. Knowing what one has a disease is always the first step to

surviving it. With the JOYSBIO Monkeypox antigen and antibody rapid tests,

getting those answers will be much faster and allow healthcare workers to

protect themselves and the public better.

"At JOYSBIO," Zhang said. "We're committed to keeping up with all infectious

threats to humanity. We will continue to improve our existing tests and develop

new ones as needed. The sooner one knows that they're ill, the sooner they can

take proactive steps to prevent spread and take care of oneself."

About JOYSBIO

JOYSBIO (Tianjin) Biotechnology Co., Ltd. is an R&D-focused Chinese

biotechnology company that develops, manufactures, and supplies high-quality

medical in-vitro diagnostic (IVD) rapid test kits as well as revolutionary

customized reagent kits to all parts of the world. JOYSBIO was founded by a

team of professionals with many years of combined technical, marketing/sales,

operational, and manufacturing expertise in this industry. JOYSBIO is a

world-leading lateral flow test kit developer and manufacturer that supplied

more than 200 million units of SARS-COV-2 rapid test kits during the COVID-19

outbreak.

If you would like more information about this topic, please contact Rick Zhang

at +86-130-7204-9899 or email at bd@joysbio.com.

SOURCE: JOYSBIO (Tianjin) Biotechnology Co., Ltd.